The epidemiology of vitamin D and cancer risk

Vitamin D

Volumn , Issue , 2011, Pages 1569-1590

  Giovannucci, Edward ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884772603     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381978-9.10082-4     Document Type: Chapter

References (135)

1. Peller S., Stephenson C.S. Skin irritation and cancer in the United States Navy. Am. J. Med. Sci. 1937, 194:326-333.
2. Apperly F.L. The relation of solar radiation to cancer mortality in North American. Cancer Res. 1941, 1:191-195.
3. Garland C.F., Garland F.C. Do sunlight and vitamin D reduce the likelihood of colon cancer?. Int. J. Epidemiol. 1980, 9:227-231.
4. Garland F.C., Garland C.F., Gorham E.D., Young J.F. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev. Med. 1990, 19:614-622.
5. Lefkowitz E.S., Garland C.F. Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int. J. Epidemiol. 1994, 23:1133-1136.
6. Schwartz G.G., Hulka B.S. Is vitamin D deficiency a risk factor for prostate cancer?. (Hypothesis.) Anticancer. Res. 1990, 10:1307-1311.
7. Hanchette C.L., Schwartz G.G. Geographic patterns of prostate cancer mortality. Cancer 1992, 70:2861-2869.
8. Grant W.B. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 2002, 94:1867-1875.
9. Narbaitz R., Stumpf W.E., Sar M. The role of autoradiographic and immunocytochemical techniques in the clarification of sites of metabolism and action of vitamin D. J. Histochem. Cytochem. 1981, 29:91-100.
10. Martínez M.E., Marshall J.R., Giovannucci E. Diet and cancer prevention: the roles of observation and experimentation. Nat. Rev. Cancer 2008, 8:694-703.
11. Platz E.A., Rimm E.B., Willett W.C., Kantoff P.W., Giovannucci E. Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals. J. Natl. Cancer Inst. 2000, 92:2009-2017.
12. Hofmann J.N., Yu K., Horst R.L., Hayes R.B., Purdue M.P. Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol. Biomarkers Prev. 2010, 19:927-931.
13. Jorde R., Sneve M., Hutchinson M., Emaus N., Figenschau Y., Grimnes G. Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am. J. Epidemiol. 2010, 171:903-908.
14. Holick M.F. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am. J. Clin. Nutr. 2004, 79:362-371.
15. Hollis B.W. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J. Nutr. 2005, 135:317-322.
16. Vieth R. The pharmacology of vitamin D, including fortification strategies. Vitamin D 2005, 995-1015. Elsevier Academic Press, Amsterdam. second ed. D. Feldman, J.W. Pike, F.H. Glorieux (Eds.).
17. Millen A.E., Wactawski-Wende J., Pettinger M., Melamed M.L., Tylavsky F.A., Liu S., et al. Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: the Women's Health Initiative Calcium plus Vitamin D clinical trial. Am. J. Clin. Nutr. 2010, 91:1324-1335.
18. Garland C.F., Comstock G.W., Garland F.C., Helsing K.J., Shaw E.K., Gorham E.D. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 1989, 2:1176-1178.
19. Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis B., Virtamo J., et al. Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 1997, 8:615-625.
20. Feskanich D., Ma J., Fuchs C.S., Kirkner G.J., Hankinson S.E., Hollis B.W., et al. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev. 2004, 13:1502-1508.
21. Levine A.J., Harper J.M., Ervin C.M., Chen Y.H., Harmon E., Xue S., et al. Serum 25-hydroxyvitamin D, dietary calcium in take, and distal colorectal adenoma risk. Nutr. Cancer 2001, 39:35-41.
22. Peters U., McGlynn K.A., Chatterjee N., Gunter E., Garcia-Closas M., Rothman N., et al. Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas. Cancer. Epidemiol. Biomarkers Prev. 2001, 10:1267-1274.
23. Platz E.A., Hankinson S.E., Hollis B.W., Colditz G.A., Hunter D.J., Speizer F.E., et al. Plasma 1,25-dihydroxy-and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol. Biomarkers Prev. 2000, 9:1059-1065.
24. Grau M.V., Baron J.A., Sandler R.S., Haile R.W., Beach M.L., Church T.R., et al. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trail. J. Natl. Cancer Inst. 2003, 95:1765-1771.
25. Braun M.M., Helzlsouer K.J., Hollis B.W., Comstock G.W. Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States). Cancer Causes Control 1995, 6:235-239.
26. Wactawski-Wende J., Kotchen J.M., Anderson G.L., Assaf A.R., Brunner R.L., O'Sullivan M.J., et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N. Engl. J. Med. 2006, 354:684-696.
27. Gorham E.D., Garland C.F., Garland F.C., Grant W.B., Mohr S.B., Lipkin M., et al. Optimal vitamin D status for colorectal cancer prevention. A quantitative meta analysis. Am. J. Prev. Med. 2007, 32:210-216.
28. Gandini S., Boniol M., Haukka J., Byrnes G., Cox B., Sneyd M.J., et al. (Epub ahead of print) Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int. J. Cancer 2010 May 6.
29. Wu K., Feskanich D., Fuchs C.S., Willett W.C., Hollis B.W., Giovannucci E.L. A nested case-control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J. Natl. Cancer Inst. 2007, 99:1120-1129.
30. Otani T., Iwasaki M., Sasazuki S., Inoue M., Tsugane S. Plasma vitamin D and risk of colorectal cancer: the Japan Public Health Center-Based Prospective Study. Br. J. Cancer 2007, 97:446-451.
31. Freedman D.M., Looker A.C., Chang S.C., Graubard B.I. Prospective study of serum vitamin D and cancer mortality in the United States. J. Natl. Cancer Inst. 2007, 99:1594-1602.
32. Jenab M., Bueno-de-Mesquita H.B., Ferrari P., van Duijnhoven F.J., Norat T., Pischon T., et al. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested case-control study. BMJ 2010, 340:b5500.
33. Woolcott C.G., Wilkens L.R., Nomura A.M., Horst R.L., Goodman M.T., Murphy S.P., et al. Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev. 2010, 19:130-134.
34. Peters U., Hayes R.B., Chatterjee N., Shao W., Schoen R.E., Pinsky P., et al. Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. The Prostate, Lung, Colorectal and Ovarian Cancer Screening Project Team. Cancer Epidemiol Biomarkers Prev. 2004, 13:546-552.
35. Wei M.Y., Garland C.F., Gorham E.D., Mohr S.B., Giovannucci E. Vitamin D and prevention of colorectal adenoma: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008, 17:2958-2969.
36. Samad A.K., Taylor R.S., Marshall T., Chapman M.A. A meta-analysis of the association of physical activity with reduced risk of colorectal cancer. Colorectal Dis. 2005, 7:204-213.
37. Giovannucci E., Liu Y., Platz E.A., Stampfer M.J., Willett W.C. Risk factors for prostate cancer incidence and progression in the Health Professionals Follow-up Study. Int. J. Cancer 2007, 121:1571-1578.
38. Garland C., Shekelle R.B., Barrett-Conner E., Criqui M.H., Rossof A.H., Paul O. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 1985, 1:307-309.
39. Kearney J., Giovannucci E., Rimm E.B., Ascherio A., Stampfer M.J., Colditz G.A., et al. Calcium, vitamin D and dairy foods and the occurrence of colon cancer in men. Am. J. Epidemiol. 1996, 143:907-917.
40. Bostick R.M., Potter J.D., Sellers T.A., McKenszie D.R., Kushi H., Folsom A.R. Relation of calcium, vitamin D, and dairy food intake to incidence of colon cancer in older women. Am. J. Epidemiol. 1993, 137:1302-1317.
41. Martinez M.E., Giovannucci E.L., Colditz G.A., Stampfer M.J., Hunter D.J., Speizer F.E., et al. Calcium, vitamin D, and the occurrence of colorectal cancer among women. J. Natl. Cancer Inst. 1996, 88:1375-1382.
42. Zheng W., Anderson K.E., Kushi L.H., Sellers T.A., Greenstein J., Hong C.P., et al. A prospective cohort study of intake of calcium, vitamin D, and other micronutrients in relation to incidence of rectal cancer among postmenopausal women. Cancer Epidemiol. Biomarkers Prev. 1998, 7:221-225.
43. Jarvinen R., Knekt P., Hakulinen T., Aromaa A. Prospective study on milk products, calcium and cancers of the colon and rectum. Eur. J. Clin. Nutr. 2001, 55:1000-1007.
44. McCullough M.L., Robertson A.S., Rodriguez C., Jacobs E.J., Chao A., Carolyn J., et al. Calcium, vitamin D, dairy products, and risk of colorectal cancer in the cancer prevention study II nutrition cohort (United States). Cancer Causes Control 2003, 14:1-12.
45. Heilbrun L.K., Nomura A., Hankin J.H., Stemmermann G.N. Dietary vitamin D and calcium and risk of colorectal cancer (letter). Lancet 1985, 1:925.
46. Benito E., Stiggelbout A., Bosch F.X., Obrador A., Kaldor J., Mulet M., et al. Nutritional factors in colorectal cancer risk: a case-control study in Majorca. Int. J. Cancer 1991, 49:161-167.
47. Peters R.K., Pike M.C., Garabrandt D., Mack T.M. Diet and colon cancer in Los Angeles County, California. Cancer Causes Control 1992, 3:457-473.
48. Ferraroni M., La Vecchia C., D'Avanzo B., Negri E., Franceschi S., Decarli A. Selected micronutrient intake and the risk of colorectal cancer. Br. J. Cancer 1994, 70:1150-1155.
49. Boutron M.C., Faivre J., Marteau P., Couillault C., Senesse P., Quipourt V. Calcium, phosphorus, vitamin D, dairy products and colorectal carcinogenesis: a French case-control study. Br. J. Cancer 1996, 74:145-151.
50. Pritchard R.S., Baron J.A., Gerhardsson de Verdier M. Dietary calcium, vitamin D, and the risk of colorectal cancer in Stockholm, Sweden. Cancer Epidemiol. Biomarkers Prev. 1996, 5:897-900.
51. Marcus P.M., Newcomb P.A. The association of calcium and vitamin D, and colon and rectal cancer in Wisconsin women. Int. J. Epidemiol. 1998, 27:788-793.
52. Kampman E., Slattery M.L., Caan B., Potter J.D. Calcium, vitamin D, sunshine exposures, dairy products and colon cancer risk (United States). Cancer Causes Control 2000, 11:459-466.
53. Park S.Y., Murphy S.P., Wilkens L.R., Stram D.O., Henderson B.E., Kolonel L.N. Calcium, vitamin D, and dairy product intake and prostate cancer risk: the Multiethnic Cohort Study. Am. J. Epidemiol. 2007, 166:1259-1269.
54. Oh K., Willett W.C., Wu K., Fuchs C.S., Giovannucci E. Calcium and vitamin D intakes in relation to risk of distal colorectal adenoma in women. Am. J. Epidemiol. 2007, 165:1178-1186.
55. Peterlik M., Grant W.B., Cross H.S. Calcium, vitamin D and cancer. Anticancer Res. 2009, 29:3687-3698.
56. Corder E.H., Guess H.A., Hulka B.S., Friedman G.D., Sadler M., Vollmer R.T., et al. Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol. Biomarkers Prev. 1993, 2:467-472.
57. Gann P.H., Ma J., Hennekens C.H., Hollis B.W., Haddad J.G., Stampfer M.J. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol. Biomarkers Prev. 1996, 5:121-126.
58. Nomura A.M., Stemmermann G.N., Lee J., Kolonel L.N., Chen T.C., Turner A., et al. Serum vitamin D metabolite levels and the subsequent development of prostate cancer. Cancer Causes Control 1998, 9:425-432.
59. Platz E.A., Leitzmann M.F., Hollis B.W., Willett W.C., Giovannucci E. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control 2004, 15:255-265.
60. Jacobs E.T., Giuliano A.R., Martinez M.E., Hollis B.W., Reid M.E., Marshall J.R. Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer. J. Steroid. Biochem. Mol. Biol. 2004, 89-90:533-537.
61. Ahonen M.H., Tenkanen L., Teppo L., Hakama M., Tuohimaa P. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 2000, 11:847-852.
62. Tuohimaa P., Tenkanen L., Ahonen M., Lumme S., Jellum E., Hallmans G., et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int. J. Cancer. 2004, 108:104-108.
63. Li H., Stampfer M.J., Hollis B.W., Mucci L.A., Gaziano J.M., Hunter D.J., et al. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med. 2007, 4:e103.
64. Ahn J., Peters U., Albanes D., Purdue M.P., Abnet C.C., Chatterjee N., et al. Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J. Natl. Cancer Inst. 2008, 100:796-804.
65. Travis R.C., Crowe F.L., Allen N.E., Appleby P.N., Roddam A.W., Tjonneland A., et al. Serum vitamin D and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition (EPIC). Am. J. Epidemiol. 2009, 169:1223-1232.
66. Giovannucci E., Rimm E.B., Wolk A., Ascherio A., Stampfer M.J., Colditz G.A., et al. Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res. 1998, 58:442-447.
67. Chan J.M., Giovannucci E., Andersson S.O., Yuen J., Adami H.O., Wolk A. Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer. Cancer Causes Control 1998, 9:559-566.
68. Chan J.M., Pietinen P., Virtanen M., Malila N., Tangrea J. Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland). Cancer Causes Control 2000, 11:859-867.
69. Kristal A.R., Cohen J.H., Qu P., Stanford J.L. Associations of energy, fat, calcium, and vitamin D with prostate cancer risk. Cancer Epidemiol. Biomarkers Prev. 2002, 11:719-725.
70. Bertone-Johnson E., Chen W.Y., Holick M.F., Hollis B.W., Colditz G., Willett W.C., et al. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev. 2005, 14:1991-1997.
71. Freedman D.M., Chang S.C., Falk R.T., Purdue M.P., Huang W.Y., McCarty C.A., et al. Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol. Biomarkers Prev. 2008, 17:889-894.
72. McCullough M.L., Stevens V.L., Patel R., Jacobs E.J., Bain E.B., Horst R.L., et al. Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort. Breast Cancer Res. 2009, 11:R64.
73. Gissel T., Rejnmark L., Mosekilde L., Vestergaard P. Intake of vitamin D and risk of breast cancer: a meta-analysis. J. Steroid. Biochem. Mol. Biol. 2008, 111:195-199.
74. Shin M.H., Holmes M.D., Hankinson S.E., Wu K., Colditz G.A., Willett W.C. Intake of dairy products, calcium, and vitamin D and risk of breast cancer. J. Natl. Cancer Inst. 2002, 94:1301-1310.
75. Gallicchio L., Helzlsouer K.J., Chow W.H., Freedman D.M., Hankinson S.E., Hartge P., et al. Circulating 25-hydroxyvitamin D and the risk of rarer cancers: design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am. J. Epidemiol. 2010, 172:10-20.
76. Helzlsouer K.J. Overview of the cohort consortium vitamin D pooling project of rarer cancers. VDPP Steering Committee. Am. J. Epidemiol. 2010, 172:4-9.
77. Abnet C.C., Chen Y., Chow W.H., Gao Y.T., Helzlsouer K.J., Le Marchand L., et al. Circulating 25-hydroxyvitamin D and risk of esophageal and gastric cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am. J. Epidemiol. 2010, 172:94-106.
78. Zeleniuch-Jacquotte A., Gallicchio L., Hartmuller V., Helzlsouer K.J., McCullough M.L., Setiawan V.W., et al. Circulating 25-hydroxyvitamin D and risk of endometrial cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am. J. Epidemiol. 2010, 172:36-46.
79. Gallicchio L., Moore L.E., Stevens V.L., Ahn J., Albanes D., Hartmuller V., et al. Circulating 25-hydroxyvitamin D and risk of kidney cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am. J. Epidemiol. 2010, 172:47-57.
80. Zheng W., Danforth K.N., Tworoger S.S., Goodman M.T., Arslan A.A., Patel A.V., et al. Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am. J. Epidemiol. 2010, 172:70-80.
81. Stolzenberg-Solomon R.Z., Jacobs E.J., Arslan A.A., Qi D., Patel A.V., Helzlsouer K.J., et al. Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am. J. Epidemiol. 2010, 172:81-93.
82. Purdue M.P., Freedman D.M., Gapstur S.M., Helzlsouer K.J., Laden F., Lim U., et al. Circulating 25-hydroxyvitamin D and risk of non-Hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am. J. Epidemiol. 2010, 172:58-69.
83. Stolzenberg-Solomon R.Z., Vieth R., Azad A., Pietinen P., Taylor P.R., Virtamo J., et al. A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res. 2006, 66:10213-10219.
84. Bao Y., Ng K., Wolpin B.M., Michaud D.S., Giovannucci E., Fuchs C.S. Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies. Br. J. Cancer 2010, 102:1422-1427.
85. Skinner H.G., Michaud D.S., Giovannucci E., Willett W.C., Colditz G.A., Fuchs C.S. Vitamin D intake and the risk for pancreatic cancer in two cohort studies. Cancer Epidemiol. Biomarkers Prev. 2006, 15:1688-1695.
86. Tworoger S.S., Lee I.M., Buring J.E., Rosner B., Hollis B.W., Hankinson S.E. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer. Cancer Epidemiol. Biomarkers Prev. 2007, 16:783-788.
87. Toriola A.T., Surcel H.M., Agborsangaya C., Grankvist K., Tuohimaa P., Toniolo P., et al. Serum 25-hydroxyvitamin D and the risk of ovarian cancer. Eur. J. Cancer 2010, 46:364-369.
88. Toriola A.T., Surcel H.M., Calypse A., Grankvist K., Luostarinen T., Lukanova A., et al. (Epub ahead of print) Independent and joint effects of serum 25-hydroxyvitamin D and calcium on ovarian cancer risk: a prospective nested case-control study. Eur. J. Cancer 2010 Jun 18.
89. Chen W., Dawsey S.M., Qiao Y.L., Mark S.D., Dong Z.W., Taylor P.R., et al. Prospective study of serum 25(OH)-vitamin D concentration and risk of oesophageal and gastric cancers. Br. J. Cancer 2007, 97:123-128.
90. Abnet C.C., Chen W., Dawsey S.M., Wei W.Q., Roth M.J., Liu B., et al. Serum 25(OH)-vitamin D concentration and risk of esophageal squamous dysplasia. Cancer Epidemiol. Biomarkers Prev. 2007, 16:1889-1893.
91. Pilz S., Dobnig H., Winklhofer-Roob B., Riedmüller G., Fischer J.E., Seelhorst U., et al. Low serum levels of 25-hydroxyvitamin D predict fatal cancer in patients referred to coronary angiography. Cancer Epidemiol. Biomarkers Prev. 2008, 17:1228-1233.
92. Ducloux D., Courivaud C., Bamoulid J., Kazory A., Dumoulin G., Chalopin J.M. Pretransplant serum vitamin D levels and risk of cancer after renal transplantation. Transplantation 2008, 85:1755-1759.
93. Boscoe F.P., Schymura M.J. Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993-2002. BMC Cancer 2006, 6:264.
94. Mizoue T. Ecological study of solar radiation and cancer mortality in Japan. Health Phys. 2004, 87:532-538.
95. Chen W., Clements M., Rahman B., Zhang S., Qiao Y., Armstrong B.K. (Epub ahead of print) Relationship between cancer mortality/incidence and ambient ultraviolet B irradiance in China. Cancer Causes Control 2010 Jun 16.
96. Freedman D.M., Dosemeci M., McGlynn K. Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study. Occup. Environ. Med. 2002, 59:257-262.
97. Freedman D.M., Zahm S.H., Dosemeci M. Residential and occupational exposure to sunlight and mortality from non-Hodgkin's lymphoma: composite (threefold) case-control study. BMJ 1997, 314:1451-1455.
98. John E.M., Schwartz G.G., Koo J., Van Den Berg D., Ingles S.A. Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. Cancer Res. 2005, 65:5470-5479.
99. John E.M., Koo J., Schwartz G.G. Sun exposure and prostate cancer risk: evidence for a protective effect of early-life exposure. Cancer Epidemiol. Biomarkers Prev. 2007, 16:1283-1286.
100. Luscombe C.J., Fryer A.A., French M.E., Liu S., Saxby M.F., Jones P.W., et al. Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer. Lancet 2001, 358:641-642.
101. Bodiwala D., Luscombe C.J., French M.E., Liu S., Saxby M.F., Jones P.W., et al. Associations between prostate cancer susceptibility and parameters of exposure to ultraviolet radiation. Cancer Lett. 2003, 200:141-148.
102. Edvardsen K., Veierod M.B., Brustad M., Braaten T., Engelsen O., Lund E. (Epub ahead of print) Vitamin D - effective solar UV radiation, dietary vitamin D and breast cancer risk. Int. J. Cancer 2010 May 13.
103. Knight J.A., Lesosky M., Barnett H., Raboud J.M., Vieth R. Vitamin D and reduced risk of breast cancer: a population-based case-control study. Cancer Epidemiol. Biomarkers Prev. 2007, 16:422-429.
104. John E.M., Schwartz G.G., Koo J., Wang W., Ingles S.A. Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population. Am. J. Epidemiol. 2007, 166:1409-1419.
105. John E.M., Schwartz G.G., Dreon D.M., Koo J. Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971-1975 to 1992. National Health and Nutrition Examination Survey. Cancer Epidemiol. Biomarkers Prev. 1999, 8:399-406.
106. Kricker A., Armstrong B.K., Hughes A.M., Goumas C., Smedby K.E., Zheng T., et al. Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int. J. Cancer 2008, 122:144-154.
107. Norval M., McLoone P., Lesiak A., Narbutt J. The effect of chronic ultraviolet radiation on the human immune system. Photochem. Photobiol. 2008, 84:19-28.
108. Chlebowski R.T., Johnson K.C., Kooperberg C., Pettinger M., Wactawski-Wende J., Rohan T., et al. Calcium plus vitamin D supplementation and the risk of breast cancer. J. Natl. Cancer Inst. 2008, 100:1581-1591.
109. Ding E.L., Mehta S., Fawzi W.W., Giovannucci E.L. Interaction of estrogen therapy with calcium and vitamin D supplementation on colorectal cancer risk: Reanalysis of Women's Health Initiative randomized trial. Int. J. Cancer 2008, 122:1690-1694.
110. Freedman D.M., Rajaraman P., Fuhrman B., Hoffbeck R., Alexander B.H. (Epub ahead of print) Sunlight, hormone replacement status and colorectal cancer risk in post-menopausal women. Int. J. Cancer 2009 Sep 30.
111. Protiva P., Cross H.S., Hopkins M.E., Kallay E., Bises G., Dreyhaupt E., et al. Chemoprevention of colorectal neoplasia by estrogen: potential role of vitamin D activity. Cancer Prev. Res. 2009, 2:43-51.
112. Trivedi D.P., Doll R., Khaw K.T. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomized double blind controlled trial. BMJ 2003, 326:469-475.
113. Lappe J.M., Travers-Gustafson D., Davies K.M., Recker R.R., Heaney R.P. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am. J. Clin. Nutr. 2007, 85:1586-1591.
114. Rukin N., Blagojevic M., Luscombe C.J., Liu S., Saxby M.F., Ramachandran S., et al. Associations between timing of exposure to ultraviolet radiation, T-stage and survival in prostate cancer. Cancer Detect. Prev. 2007, 31:443-449.
115. Ng K., Meyerhardt J.A., Wu K., Feskanich D., Hollis B.W., Giovannucci E.L., et al. Circulating 25-hydroxyvitamin D levels and survival in patients with colorectal cancer. J. Clin. Oncol. 2008, 26. 2984-1991.
116. Zhou W., Heist R.S., Liu G., Asomaning K., Neuberg D.S., Hollis B.W., et al. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J. Clin. Oncol. 2007, 25:479-485.
117. Heist R.S., Zhou W., Wang Z., Liu G., Neuberg D., Su L., et al. Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer. J. Clin. Oncol. 2008, 26:5596-5602.
118. Skeie G., Braaten T., Hjartaker A., Brustad M., Lund E. Cod liver oil, other dietary supplements and survival among cancer patients with solid tumours. Int. J. Cancer 2009, 125:1155-1160.
119. Goodwin P.J., Ennis M., Pritchard K.I., Koo J., Hood N. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J. Clin. Oncol. 2009, 27:3757-3763.
120. Neuhouser M.L., Sorensen B., Hollis B.W., Ambs A., Ulrich C.M., McTiernan A., et al. Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors. Am. J. Clin. Nutr. 2008, 88:133-139.
121. Newton-Bishop J.A., Beswick S., Randerson-Moor J., Chang Y.M., Affleck P., Elliott F., et al. Serum 25-hydroxyvitamin D3 levels are associated with Breslow thickness at presentation and survival from melanoma. J. Clin. Oncol. 2009, 27:5439-5444.
122. Meyer F., Liu G., Douville P., Samson E., Xu W., Adjei A., et al. (Epub ahead of print) Dietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients. Int. J. Cancer 2010 Jun 7.
123. Mezawa H., Sugiura T., Watanabe M., Norizoe C., Takahashi D., Shimojima A., et al. Serum vitamin D levels and survival of patients with colorectal cancer: post-hoc analysis of a prospective cohort study. BMC Cancer 2010, 10:347.
124. Tretli S., Hernes E., Berg J.P., Hestvik U.E., Robsahm T.E. Association between serum 25(OH)D and death from prostate cancer. Br. J. Cancer 2009, 100:450-454.
125. Ng K., Wolpin B.M., Meyerhardt J.A., Wu K., Chan A.T., Hollis B.W., et al. Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer. Br. J. Cancer 2009, 101:916-923.
126. Porojnicu A., Robsahm T.E., Berg J.P., Moan J. Season of diagnosis is a predictor of cancer survival. Sun-induced vitamin D may be involved: a possible role of sun-induced Vitamin D. J. Steroid. Biochem. Mol. Biol. 2007, 103:675-678.
127. Moan J., Porojnicu A.C., Robsahm T.E., Dahlback A., Juzeniene A., Tretli S., et al. Solar radiation, vitamin D and survival rate of colon cancer in Norway. J. Photochem. Photobiol. B. 2005, 78:189-193.
128. Moan J., Dahlback A., Lagunova Z., Cicarma E., Porojnicu A.C. Solar radiation, vitamin D and cancer incidence and mortality in Norway. Anticancer Res. 2009, 29:3501-3509.
129. Roychoudhuri R., Robinson D., Coupland V., Holmberg L., Moller H. Season of cancer diagnosis exerts distinct effects upon short- and long-term survival. Int. J. Cancer 2009, 124:2436-2441.
130. Holmberg L., Adolfsson J., Mucci L., Garmo H., Adami H.O., Moller H., et al. Season of diagnosis and prognosis in breast and prostate cancer. Cancer Causes Control 2009, 20:663-670.
131. Sundaram S., Sea A., Feldman S., Strawbridge R., Hoopes P.J., Demidenko E., et al. The combination of a potent vitamin D3 analog, EB 1089, with ionizing radiation reduces tumor growth and induces apoptosis of MCF-7 breast tumor xenografts in nude mice. Clin. Cancer Res. 2003, 9:2350-2356.
132. Schwartz G.G., Hanchette C.L. UV, latitude, and spatial trends in prostate cancer mortality: all sunlight is not the same (United States). Cancer Causes Control 2006, 17:1091-1101.
133. Whitlatch L.W., Young M.V., Schwartz G.G., Flanagan J.N., Burnstein K.L., Lokeshwar B.L., et al. 25-Hydroxyvitamin D-1alpha-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer. J. Steroid Biochem. Mol. Biol. 2002, 81:135-140.
134. Chen T.C., Wang L., Whitlatch L.W., Flanagan J.N., Holick M.F. Prostatic 25-hydroxyvitamin D-1alpha-hydroxylase and its implication in prostate cancer. J. Cell Biochem. 2003, 88:315-322.
135. Hendrickson W.K., Flavin R., Kasperzyk J.L., Fiorentino M., Fang F., Lis R., et al. Vitamin D receptor protein expression in tumor tissue and prostate cancer progression. J. Clin. Oncol. in press 2011.